XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock Compensation | 9 Months Ended
--- | ---
Sep. 30, 2021
Share-based Payment Arrangement [Abstract] |
Stock Compensation | STOCK COMPENSATION The Corporation has a stock incentive plan, which is administered by a committee of the Board of Directors and which permits the Corporation to provide various types of stock-based compensation to its key employees, directors, and/or consultants, including time-based and performance-based shares of restricted stock. The Corporation previously maintained the CNB Financial Corporation 2009 Stock Incentive Plan, which terminated in accordance with its terms on February 10, 2019, and currently maintains the CNB Financial Corporation 2019 Omnibus Incentive Plan (the "2019 Stock Incentive Plan"), which was approved by the Corporation’s shareholders and became effective on April 16, 2019. For key employees, the vesting of time-based restricted stock is one-third, one-fourth, or one-fifth of the granted restricted shares per year, beginning one year after the grant date, with 100% vesting on the third, fourth or fifth anniversary of the grant date, respectively. Prior to 2018, for non-employee directors, the vesting schedule was one-third of the granted restricted shares per year, beginning one year after the grant date, with 100% vested on the third anniversary of the grant date. Beginning in 2018, stock compensation received by non-employee directors vests immediately. At September 30, 2021, there was no unrecognized compensation cost related to stock-based compensation awarded under this plan and, except for the time-based and performance-based restricted stock awards disclosed below and in previous filings, no other stock-based compensation was granted during the three month period ended September 30, 2021 and 2020. Compensation expense for the restricted stock awards is recognized over the requisite service period based on the fair value of the shares at the date of grant on a straight-line basis. Non-vested restricted stock awards are recorded as a reduction of additional paid-in-capital in shareholders’ equity until earned. Compensation expense resulting from time-based, performance-based and director restricted stock awards was $312 and $1,124 for the three and nine months ended September 30, 2021, respectively, and $288 and 1,123 for the three and nine months ended September 30, 2020, respectively. The total income tax benefit related to the recognized compensation cost of vested restricted stock awards was $65 and $236 for the three and nine months ended September 30, 2021, respectively, and $60 and $235 for the three and nine months ended September 30, 2020, respectively. A summary of changes in time-based unvested restricted stock awards for the three months ended September 30, 2021 follows:
| Shares |  | Per Share Weighted Average Grant Date Fair Value
Unvested at beginning of period | 66,801 |  |  | $ | 24.02 |
Granted | 2,203 |  |  | 24.30 |
Vested | (361) |  |  | 16.60 |
Unvested at end of period | 68,643 |  |  | $ | 24.07 |
A summary of changes in time-based unvested restricted stock awards for the nine months ended September 30, 2021 follows:
| Shares |  | Per Share Weighted Average Grant Date Fair Value
Unvested at beginning of period | 56,306 |  |  | $ | 27.14 |
Granted | 37,423 |  |  | 21.28 |
Forfeited | (1,578) |  |  | 26.82 |
Vested | (23,508) |  |  | 26.80 |
Unvested at end of period | 68,643 |  |  | $ | 24.07 |
The above table excludes 14,886 shares in restricted stock awards that were granted at a weighted average fair value of $21.03 and immediately vested. There was $1,258 and $1,055 of total unrecognized compensation cost related to unvested restricted stock awards, as of September 30, 2021 and December 31, 2020, respectively. The fair value of shares vested was $9 and $814 during the three and nine months ended September 30, 2021, respectively, and $3 and 1,109 during the three and nine months ended September 30, 2020, respectively. In addition to the time-based restricted stock disclosed above, the Corporation’s Board of Directors grants performance-based restricted stock awards (“PBRSAs”) to key employees. The number of PBRSAs will depend on certain performance conditions earned over a three year period and are also subject to service-based vesting. In 2021, awards with a maximum of 18,210 shares in aggregate were granted to key employees. In 2020, awards with a maximum of 18,100 shares in aggregate were granted to key employees. In 2019, awards with a maximum of 16,681 shares in aggregate were granted to key employees. In 2020, the 2018 PBRSAs were fully earned and in 2021, 10,587 shares were fully distributed. The fair value of the shares distributed in 2021 was $223.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration